Synch has acted as legal advisor to the shareholders of Epiluvac AB (“Epiluvac”) in the sale of Epiluvac to the NASDAQ listed company Veeco Instruments Inc.
Epiluvac is a privately held Swedish company founded in 2013 by a team of engineers with decades of research and development experience from the CVD reactor field and especially hot-wall CVD epitaxy equipment for Silicon Carbide. Epiluvac provides standard as well as customized reactor solutions and a wide range of service and maintenance packages. Recent customized solutions include reactor designs for graphene and nanowire manufacturing, among others.
”Synch has been professional, efficient, accessible, and on top of that, a pleasure to work with. We are incredibly thankful to have Synch as our legal advisors!”, Claes Wallnér, transaction project leader and shareholder.
“We highly appreciated Synch’s pragmatic approach, expertise, and efficiency in structuring an international transaction. Synch’s ability to focus on what is important to move a deal forward, combined with their strategic and structured project management, made the sale efficient and smooth from a shareholders’ perspective.”, Roger Nilsson & Richard Spengler, co-founders and shareholders.
Synch’s team consisted of Carl-Adam Drakenberg, Amanda Espinasse, and Amanda Luthman.
Synch is a law firm focusing on digital business and technology. Synch is offering a flexible delivery model where Digital Services complement the firm’s Advisory Services, Projects & Transaction Services, and Managed Services. Synch’s Projects & Transactions group is specialized in private and public M&A, venture capital investments, and financing, especially in relation to technology.
